Skip to content

NAVIDEA BIOPHARMACEUTICALS, INC.: 10-K filed 2014-03-14

What NAVIDEA BIOPHARMACEUTICALS, INC. reported in its annual report filed 2014-03-14 (fiscal FY 2013): 42 published measures, 145 facts as tagged in accession 0001445305-14-001051.

This filing

Form
10-K (annual report)
Filed
2014-03-14
Fiscal period
fiscal FY 2013
Accession
0001445305-14-001051 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All NAVIDEA BIOPHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3140,316,517USD
At 2012-12-3111,972,397USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3144,326,104USD
At 2012-12-3113,377,773USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31-4,009,587USD
At 2012-12-31-1,405,376USD
At 2011-12-3121,131,747USD
At 2010-12-314,131,745USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3132,939,026USD
At 2012-12-319,118,564USD
At 2011-12-3128,644,004USD
At 2010-12-316,420,506USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-13,752,000USD92
2013-01-01 to 2013-12-31-42,699,458USD365
2013-07-01 to 2013-09-30-11,306,000USD92
2013-04-01 to 2013-06-30-10,300,000USD91
2013-01-01 to 2013-03-31-7,341,000USD90
2012-10-01 to 2012-12-31-7,203,000USD92
2012-01-01 to 2012-12-31-29,157,204USD366
2012-07-01 to 2012-09-30-9,124,000USD92
2012-04-01 to 2012-06-30-5,860,000USD91
2012-01-01 to 2012-03-31-7,014,000USD91
2011-01-01 to 2011-12-315,612,992USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-35,612,075USD365
2012-01-01 to 2012-12-31-23,923,319USD366
2011-01-01 to 2011-12-31-16,010,005USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,239,666USD365
2012-01-01 to 2012-12-31663,348USD366
2011-01-01 to 2011-12-31183,830USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,130,630USD365
2012-01-01 to 2012-12-3178,738USD366
2011-01-01 to 2011-12-31597,729USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-3160,724,904USD365
2012-01-01 to 2012-12-315,069,687USD366
2011-01-01 to 2011-12-3111,075,242USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,292,367USD365
2012-01-01 to 2012-12-31-671,808USD366
2011-01-01 to 2011-12-3127,158,261USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-317,257,302USD
At 2012-12-31-274,557,844USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-310USD366
2011-01-01 to 2011-12-31-7,880,143USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-312,125,383USD
At 2012-12-31934,578USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,908,269USD365
2012-01-01 to 2012-12-312,304,118USD366
2011-01-01 to 2011-12-313,592,090USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-13,053,000USD92
2013-01-01 to 2013-12-31-38,438,314USD365
2013-07-01 to 2013-09-30-9,925,000USD92
2013-04-01 to 2013-06-30-8,456,000USD91
2013-01-01 to 2013-03-31-7,004,000USD90
2012-10-01 to 2012-12-31-7,026,000USD92
2012-01-01 to 2012-12-31-27,989,303USD366
2012-07-01 to 2012-09-30-9,069,000USD92
2012-04-01 to 2012-06-30-5,387,000USD91
2012-01-01 to 2012-03-31-6,506,000USD91
2011-01-01 to 2011-12-31-24,104,415USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3137,331,182USD
At 2012-12-3110,617,383USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,778,780USD365
2012-01-01 to 2012-12-311,166,332USD366
2011-01-01 to 2011-12-3113,330USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-3111,290,962USD
At 2012-12-316,190,539USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-12-312,422,349USD
At 2012-12-311,417,463USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-12-31136,854USD
At 2012-12-3192,482USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-31100,875USD366
2011-01-01 to 2011-12-310USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-10-01 to 2013-12-3113,436,000USD92
2013-01-01 to 2013-12-3139,236,129USD365
2013-07-01 to 2013-09-3010,250,000USD92
2013-04-01 to 2013-06-308,546,000USD91
2013-01-01 to 2013-03-317,004,000USD90
2012-10-01 to 2012-12-317,033,000USD92
2012-01-01 to 2012-12-3128,068,041USD366
2012-07-01 to 2012-09-309,069,000USD92
2012-04-01 to 2012-06-305,447,000USD91
2012-01-01 to 2012-03-316,518,000USD91
2011-01-01 to 2011-12-3124,702,144USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-312,232,436USD
At 2012-12-31297,500USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-31383,000USD92
2013-01-01 to 2013-12-31797,815USD365
2013-07-01 to 2013-09-30325,000USD92
2013-04-01 to 2013-06-3090,000USD91
2013-01-01 to 2013-03-310USD90
2012-10-01 to 2012-12-317,000USD92
2012-01-01 to 2012-12-3178,738USD366
2012-07-01 to 2012-09-300USD92
2012-04-01 to 2012-06-3060,000USD91
2012-01-01 to 2012-03-3112,000USD91
2011-01-01 to 2011-12-31597,729USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-01-01 to 2013-12-3115,525,946USD365
2012-01-01 to 2012-12-3111,177,559USD366
2011-01-01 to 2011-12-319,547,779USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-3123,710,183USD365
2012-01-01 to 2012-12-3116,890,482USD366
2011-01-01 to 2011-12-3115,154,365USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-31135,919,423shares
At 2012-12-31113,018,772shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-31313,111,788USD
At 2012-12-31273,039,442USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-313,609,059USD
At 2012-12-312,026,895USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-311,483,676USD
At 2012-12-311,092,317USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-31723,098USD
At 2012-12-31327,954USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-311,770,452USD
At 2012-12-31257,122USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-12-311,009,094USD
At 2012-12-311,183,714USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-42,699,458USD365
2012-01-01 to 2012-12-31-29,200,537USD366
2011-01-01 to 2011-12-315,512,992USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-12-31400,304USD365
2012-01-01 to 2012-12-31198,822USD366
2011-01-01 to 2011-12-31175,296USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,877USD365
2012-01-01 to 2012-12-311,400USD366
2011-01-01 to 2011-12-311,248USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-16,863USD365
2012-01-01 to 2012-12-31-58,723USD366
2011-01-01 to 2011-12-31-3,211USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-4,261,144USD365
2012-01-01 to 2012-12-31-1,167,901USD366
2011-01-01 to 2011-12-31-943,161USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-12-3141,303,750USD365
2013-09-01 to 2013-09-3030,000,000USD30
2012-01-01 to 2012-12-312,724,189USD366
2011-01-01 to 2011-12-317,198,373USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,042,280USD365
2012-01-01 to 2012-12-31-6,499USD366
2011-01-01 to 2011-12-31219,021USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,934,936USD365
2012-01-01 to 2012-12-31-524,049USD366
2011-01-01 to 2011-12-3153,289USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,003,515USD365
2012-01-01 to 2012-12-31736,109USD366
2011-01-01 to 2011-12-31-538,666USD365

Inspect the source

Entity
NAVIDEA BIOPHARMACEUTICALS, INC. / CIK 0000810509
Captured
SEC response SHA-256
e6e15b291454205779be87d7d17e86894a378fd299b7dd1312591814ed2d7c83

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000810509.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))